News
Much like many figures in Greek mythology, Atalanta has two different origin stories. In the first, the mortal heroine is the ...
Gasperini, who coached Atalanta from 2016 to 2025, and marked one of the most successful eras at the club, including the 2023-24 UEFA Europa League win, will now start a new chapter at Roma.
A 26-year-old Atalanta fan, Riccardo Claris, was stabbed to death last night after clashes between groups of La Dea and Inter supporters in Bergamo. A 26-year-old Atalanta supporter was killed ...
Tuttosport newspaper reports that Atalanta and Tottenham are among the clubs interested in ex-Juventus coach Thiago Motta, whose appointment would help the Bianconeri save €15m. Atalanta and ...
Arrigo Sacchi has explained what to expect from both Atalanta and Inter ahead of their Serie A title showdown on Sunday evening, but admits that tonight’s game is ‘impossible’ to call ahead ...
MILAN (AP) — Ademola Lookman and his coach Gian Piero Gasperini appear to have made up. That can only be a good thing for Atalanta’s Serie A title chances.. The pair was involved in a public ...
MILAN (AP) — Ademola Lookman and his coach Gian Piero Gasperini appear to have made up. That can only be a good thing for Atalanta’s Serie A title chances.
Atalanta's Sead Kolasinac and Ademola Lookman celebrate during the Serie A soccer match between Juventus and Atalanta at Allianz Stadium in Turin, Italy, Sunday, March 9, 2025.
AC Milan, Atalanta and Juventus were all expected to join Inter in the Champions League round of 16. But after an upset-filled knockout stage playoffs, only Inter remain.
4mon
90min on MSNAtalanta vs Club Brugge: Preview, predictions and lineups - MSNPreviewing Atalanta vs Club Brugge in the Champions League play-offs, including how to watch on TV and live stream, team news ...
Dr. Alice Atalanta, Ph.D. is an academic, an action & combat sports coach, and a military and law enforcement advocate—but first and foremost, she is an empowerment educator. Her multifaceted ...
Atalanta Therapeutics has bagged $97 million, money the biotech plans to use to launch clinical trials for its small interfering RNA (siRNA) candidates in epilepsy and Huntington’s disease. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results